| Charge |
| Chair | |
|---|---|
| David Henderson, M.D. Chair and Psychiatrist-in-Chief Boston University School of Medicine Boston, MA |
| Members | |
|---|---|
| Lynsey Bilsland, Ph.D. Partner Wellcome Trust London, UK Anita Everitt, M.D., DFAPA Director, Center for Mental Health Services Substance Abuse and Mental Health Services Administration Rockville, MD Ken Duckworth, M.D. Chief Medical Officer National Alliance on Mental Illness Arlington, VA Tristan Gorrindo, M.D. Deputy Medical Director Chief, Division of Education American Psychiatric Association Washington D.C. Mona Hicks, Ph.D. Director, Science and Technology One Mind Rutherford, CA | Sharon Mates, Ph.D. Chairman, President, and Chief Executive Officer Intra-Cellular Therapies, Inc. New York, NY Patricio O’Donnell, M.D., Ph.D. Executive Medical Director Takeda Pharmaceuticals Cambridge, MA Michael Sand, Ph.D. Senior Clinical Program Leader Boehringer-Ingelheim New York, NY Adam Savitz, M.D., Ph.D. Director, Clinical Research Janssen Research & Development Greenwich, CT Pamela Wolf, PharmD Medical Science Liaison Otsuka Pharmaceuticals Companies (U.S.) Fargo, ND |
| National Institute of Mental Health Staff | |
|---|---|
| Linda Brady, Ph.D. Federal Liaison Director, DNBBS | Nicole North, M.P.H. Federal Coordinator Scientific Program Analyst, DNBBS |
160788 Default English namhc-workgroups